New Publication:
Automated tumor immunophenotyping predicts clinical benefit from anti-PD-L1 immunotherapy

Home > Science Hub > New Publication:
Automated tumor immunophenotyping predicts clinical benefit from anti-PD-L1 immunotherapy
Back to the list

April 11, 2024

You might also be interested by

Brochures & Infographics

Advance Your ADC Programs with CellCarta

April 16, 2025

More info

Posters

Qualification of Gene and Protein Signatures from CITE-seq Data for Deep Immunophenotyping in Human Clinical Trials

April 7, 2025

More info

Posters

Beyond Affinity: Simplifying ADC quantitation without compromising sensitivity.

April 7, 2025

More info

Brochures & Infographics

Genomic Assay List

April 7, 2025

More info